You are here

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Chronic cystoid macular oedema treated with intravitreal dobesilate
  1. Pedro Cuevas1,
  2. Luis A Outeiriño2,
  3. Javier Angulo1,
  4. Guillermo Giménez-Gallego3
  1. 1Department of Research, Hospital Ramon y Cajal, Madrid, Spain
  2. 2Department of Ophthalmology, Hospital de Día Pio XII, Madrid, Spain
  3. 3Department of Qiimica de Proteinas, Centro de Investigaciones Biológicas, Madrid, Spain
  1. Correspondence to Professor Pedro Cuevas, pedro.cuevas{at}hrc.es

Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.

https://doi.org/10.1136/bcr-2012-006376

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Patient consent Obtained.